miR-132 inhibits colorectal cancer invasion and metastasis via directly targeting ZEB2

World Journal of Gastroenterology

Volumn 20, Issue 21, 2014, Pages 6515-6522

  Zheng, Yong Bin ^a   Luo, Hai Ping ^a   Shi, Qiang ^a   Hao, Zhi Nan ^a   Ding, Yu ^a   Wang, Qiu Shuang ^a   Li, Sheng Bo ^a   Xiao, Gao Chun ^a   Tong, Shi Lun ^a  

^a RENMIN HOSPITAL OF WUHAN UNIVERSITY   (China)

Author keywords

Colorectal cancer; Epithelial mesenchymal transition; Invasion; Metastasis; MicroRNA; miR 132; Prognosis

Indexed keywords

DNA; MICRORNA 132; OLIGONUCLEOTIDE; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR ZEB2; UNCLASSIFIED DRUG; HOMEODOMAIN PROTEIN; MICRORNA; MIRN132 MICRORNA, HUMAN; REPRESSOR PROTEIN; ZEB2 PROTEIN, HUMAN;

ADULT; ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CANCER PROGNOSIS; CANCER STAGING; CELL INVASION ASSAY; CLINICAL ASSESSMENT; COLORECTAL CANCER; CONTROLLED STUDY; EPITHELIAL MESENCHYMAL TRANSITION; FEMALE; GENETIC TRANSFECTION; HUMAN; HUMAN TISSUE; LUCIFERASE ASSAY; MAJOR CLINICAL STUDY; MALE; METASTASIS; MIDDLE AGED; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ISOLATION; STAINING; SURVIVAL RATE; TRANSWELL ASSAY; TUMOR INVASION; TUMOR VOLUME; WESTERN BLOTTING; AGED; ANTAGONISTS AND INHIBITORS; CELL LINE; COLORECTAL TUMOR; DISEASE COURSE; GENE EXPRESSION REGULATION; GENETICS; HCT116 CELL LINE; HEK293 CELL LINE; KAPLAN MEIER METHOD; METABOLISM; MORTALITY; PROGNOSIS; REAL TIME POLYMERASE CHAIN REACTION; TUMOR CELL LINE;

AGED; CELL LINE; CELL LINE, TUMOR; COLORECTAL NEOPLASMS; DISEASE PROGRESSION; EPITHELIAL-MESENCHYMAL TRANSITION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HCT116 CELLS; HEK293 CELLS; HOMEODOMAIN PROTEINS; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MICRORNAS; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; PROGNOSIS; REAL-TIME POLYMERASE CHAIN REACTION; REPRESSOR PROTEINS;

EID: 84902094682     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v20.i21.6515     Document Type: Article

References (27)

1. Jemal A, Siegel R, Xu J, Ward E. Cancer statistics, 2010. CA Cancer J Clin 2010; 60: 277-300 [PMID: 20610543 DOI: 10.3322/caac.20073]
2. Wood LD, Parsons DW, Jones S, Lin J, Sjöblom T, Leary RJ, Shen D, Boca SM, Barber T, Ptak J, Silliman N, Szabo S, Dezso Z, Ustyanksky V, Nikolskaya T, Nikolsky Y, Karchin R, Wilson PA, Kaminker JS, Zhang Z, Croshaw R, Willis J, Dawson D, Shipitsin M, Willson JK, Sukumar S, Polyak K, Park BH, Pethiyagoda CL, Pant PV, Ballinger DG, Sparks AB, Hartigan J, Smith DR, Suh E, Papadopoulos N, Buckhaults P, Markowitz SD, Parmigiani G, Kinzler KW, Velculescu VE, Vogelstein B. The genomic landscapes of human breast and colorectal cancers. Science 2007; 318: 1108-1113 [PMID: 17932254 DOI: 10.1126/science.1145720]
3. Pillai RS. MicroRNA function: multiple mechanisms for a tiny RNA? RNA 2005; 11: 1753-1761 [PMID: 16314451 DOI: 10.1261/rna.2248605]
4. Zamore PD, Haley B. Ribo-gnome: the big world of small RNAs. Science 2005; 309: 1519-1524 [PMID: 16141061 DOI: 10.1126/science.1111444]
5. Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004; 116: 281-297 [PMID: 14744438]
6. Esquela-Kerscher A, Slack FJ. Oncomirs - microRNAs with a role in cancer. Nat Rev Cancer 2006; 6: 259-269 [PMID: 16557279 DOI: 10.1038/nrc1840]
7. Calin GA, Croce CM. MicroRNA signatures in human cancers. Nat Rev Cancer 2006; 6: 857-866 [PMID: 17060945 DOI: 10.1038/nrc1997]
8. Bueno MJ, Pérez de Castro I, Malumbres M. Control of cell proliferation pathways by microRNAs. Cell Cycle 2008; 7: 3143-3148 [PMID: 18843198 DOI: 10.4161/cc.7.20.6833]
9. Nicoloso MS, Spizzo R, Shimizu M, Rossi S, Calin GA. MicroRNAs--the micro steering wheel of tumour metastases. Nat Rev Cancer 2009; 9: 293-302 [PMID: 19262572 DOI: 10.1038/nrc2619]
10. Yu XF, Zou J, Bao ZJ, Dong J. miR-93 suppresses proliferation and colony formation of human colon cancer stem cells. World J Gastroenterol 2011; 17: 4711-4717 [PMID: 22180714 DOI: 10.3748/wjg.v17.i42.4711]
11. Li T, Leong MH, Harms B, Kennedy G, Chen L. MicroRNA- 21 as a potential colon and rectal cancer biomarker. World J Gastroenterol 2013; 19: 5615-5621 [PMID: 24039353 DOI: 10.3748/wjg.v19.i34.5615]
12. Zhang S, Hao J, Xie F, Hu X, Liu C, Tong J, Zhou J, Wu J, Shao C. Downregulation of miR-132 by promoter methylation contributes to pancreatic cancer development. Carcinogenesis 2011; 32: 1183-1189 [PMID: 21665894 DOI: 10.1093/ carcin/bgr105]
13. Formosa A, Lena AM, Markert EK, Cortelli S, Miano R, Mauriello A, Croce N, Vandesompele J, Mestdagh P, Finazzi- Agrò E, Levine AJ, Melino G, Bernardini S, Candi E. DNA methylation silences miR-132 in prostate cancer. Oncogene 2013; 32: 127-134 [PMID: 22310291 DOI: 10.1038/onc.2012.14]
14. Roy S, Levi E, Majumdar AP, Sarkar FH. Expression of miR-34 is lost in colon cancer which can be re-expressed by a novel agent CDF. J Hematol Oncol 2012; 5: 58 [PMID: 22992310 DOI: 10.1186/1756-8722-5-58]
15. Gregory PA, Bert AG, Paterson EL, Barry SC, Tsykin A, Farshid G, Vadas MA, Khew-Goodall Y, Goodall GJ. The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1. Nat Cell Biol 2008; 10: 593-601 [PMID: 18376396 DOI: 10.1038/ncb1722]
16. Valeri N, Gasparini P, Braconi C, Paone A, Lovat F, Fabbri M, Sumani KM, Alder H, Amadori D, Patel T, Nuovo GJ, Fishel R, Croce CM. MicroRNA-21 induces resistance to 5-fluorouracil by down-regulating human DNA MutS homolog 2 (hMSH2). Proc Natl Acad Sci USA 2010; 107: 21098-21103 [PMID: 21078976 DOI: 10.1073/pnas.1015541107]
17. Wang CJ, Stratmann J, Zhou ZG, Sun XF. Suppression of microRNA-31 increases sensitivity to 5-FU at an early stage, and affects cell migration and invasion in HCT-116 colon cancer cells. BMC Cancer 2010; 10: 616 [PMID: 21062447 DOI: 10.1186/1471-2407-10-616]
18. Boni V, Bitarte N, Cristobal I, Zarate R, Rodriguez J, Maiello E, Garcia-Foncillas J, Bandres E. miR-192/miR-215 influence 5-fluorouracil resistance through cell cycle-mediated mechanisms complementary to its post-transcriptional thymidilate synthase regulation. Mol Cancer Ther 2010; 9: 2265-2275 [PMID: 20647341 DOI: 10.1158/1535-7163.MCT-10-0061]
19. Almeida MI, Nicoloso MS, Zeng L, Ivan C, Spizzo R, Gafà R, Xiao L, Zhang X, Vannini I, Fanini F, Fabbri M, Lanza G, Reis RM, Zweidler-McKay PA, Calin GA. Strand-specific miR-28- 5p and miR-28-3p have distinct effects in colorectal cancer cells. Gastroenterology 2012; 142: 886-896.e9 [PMID: 22240480 DOI: 10.1053/j.gastro.2011.12.047]
20. Wei X, Tan C, Tang C, Ren G, Xiang T, Qiu Z, Liu R, Wu Z. Epigenetic repression of miR-132 expression by the hepatitis B virus x protein in hepatitis B virus-related hepatocellular carcinoma. Cell Signal 2013; 25: 1037-1043 [PMID: 23376496 DOI: 10.1016/j.cellsig.2013.01.019]
21. Li S, Meng H, Zhou F, Zhai L, Zhang L, Gu F, Fan Y, Lang R, Fu L, Gu L, Qi L. MicroRNA-132 is frequently down-regulated in ductal carcinoma in situ (DCIS) of breast and acts as a tumor suppressor by inhibiting cell proliferation. Pathol Res Pract 2013; 209: 179-183 [PMID: 23399321 DOI: 10.1016/ j.prp.2012.12.002]
22. Zhang B, Lu L, Zhang X, Ye W, Wu J, Xi Q. Hsa-miR-132 Regulates Apoptosis in Non-Small Cell Lung Cancer Independent of Acetylcholinesterase. J Mol Neurosci 2013; Epub ahead of print [PMID: 24158730 DOI: 10.1007/s12031-013- 0136-z]
23. Taube JH, Herschkowitz JI, Komurov K, Zhou AY, Gupta S, Yang J, Hartwell K, Onder TT, Gupta PB, Evans KW, Hollier BG, Ram PT, Lander ES, Rosen JM, Weinberg RA, Mani SA. Core epithelial-to-mesenchymal transition interactome gene-expression signature is associated with claudin-low and metaplastic breast cancer subtypes. Proc Natl Acad Sci USA 2010; 107: 15449-15454 [PMID: 20713713 DOI: 10.1073/ pnas.1004900107]
24. Singh A, Settleman J. EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer. Oncogene 2010; 29: 4741-4751 [PMID: 20531305 DOI: 10.1038/ onc.2010.215]
25. Polyak K, Weinberg RA. Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits. Nat Rev Cancer 2009; 9: 265-273 [PMID: 19262571 DOI: 10.1038/nrc2620]
26. Lagos D, Pollara G, Henderson S, Gratrix F, Fabani M, Milne RS, Gotch F, Boshoff C. miR-132 regulates antiviral innate immunity through suppression of the p300 transcriptional co-activator. Nat Cell Biol 2010; 12: 513-519 [PMID: 20418869 DOI: 10.1038/ncb205]
27. Alvarez-Saavedra M, Antoun G, Yanagiya A, Oliva-Hernandez R, Cornejo-Palma D, Perez-Iratxeta C, Sonenberg N, Cheng HY. miRNA-132 orchestrates chromatin remodeling and translational control of the circadian clock. Hum Mol Genet 2011; 20: 731-751 [PMID: 21118894 DOI: 10.1093/hmg/ ddq519]